Future Aspects in Contraception Proceedings of an International Symposium held in Heidelberg, 5–8 September 1984 Part 2 Female Contraception
| Main Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Dordrecht
Springer Netherlands
1985, 1985
|
| Edition: | 1st ed. 1985 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- 28 Present and future aspects of immunological methods in contraception
- 29 Preclinical and clinical aspects of safety in contraception
- 30 The politics of contraception
- 31 Contraceptive futurology: or 1984 in 1984
- of Part 2
- 1 Natural family planning
- 2 Barrier methods of contraception
- 3 Chemistry, contraceptive activity and toxicology of aryl guanidinobenzoates: inhibitors of sperm acrosin
- 4 Measurement of LH in saliva: a new approach to ovulation detection
- 5 Steroid-induced side-effects of oral contraceptives
- 6 Efficacy and physiology of a triphasic oral contraceptive
- 7 Advantages and disadvantages of low-dose hormonal contraceptive agents
- 8 Emerging routes of delivery for fertility-control agents
- 9 Current status of NORPLANT subdermal implants for contraception
- 10 New aspects in post-coital contraception
- 11 Biological evaluation of some medicinal plant extracts for contraceptive efficacy in females
- 12 Pharmacokinetic and antigenicity studies with LHRH analogues
- 13 LHRH nasal spray in contraception
- 14 Acute and intermittent LHRH agonist dosing as post-coital and anti-ovulatory contraceptive approaches
- 15 LHRH antagonists and contraception
- 16 Mechanism of action of gonadotrophin releasing hormone in the pituitary and gonads
- 17 Morphological changes on the surface of IUDs: are they of clinical significance?
- 18 The use of non-culture tests for the detection of VD prior to IUD insertion: a view towards the future
- 19 Experience with GYNE-T Cu-380-A intrauterine contraceptive device (1981–1984)
- 20 Ten years’ experience with continuous use of the butterfly IUD
- 21 The antiprogesterone activity of RU 486, a contragestive agent in the human
- 22 Effects of the anti progesterone RU 486 in early pregnancy and during the menstrual cycle
- 23 Prostaglandins in contraception
- 24 Ovarian hormones and cybernins
- 25 Biochemical aspects of a contraception model based on immunological properties of proteohormones
- 26 Variability in antisperm andantiembryonic humoral immune responses
- 27 Research for the development of an hCG antifertility vaccine